Negotiable: Paramount Recruitment: Bioinformatics Project Manager The 100,000 genomes project is a challenging and fast moving project with the aim to carry out whole genome sequencing on 100,000 participants. London, England

Research interests of current Biostatistics faculty include GWAS, statistical genetics, pharmacogenomics, public health bioinformatics, survival analysis,...
From University of Wisconsin–Milwaukee - Fri, 06 Apr 2018 22:18:09 GMT - View all Milwaukee, WI jobs

Funding Opportunity PAR-18-746 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications for institutional research career development (K12) programs that propose to support intensive supervised research training and career development experiences for clinician scientists (Scholars) leading to research independence in the area of substance use disorder research. This FOA allows appointment of Scholars proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary study to an existing trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development

Notice NOT-OD-18-164 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-165 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-166 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Head of Software Engineering (Bioinformatics) A brilliant new opportunity has just become available for a Head of Software Engineering to join the UK's top Consumer Genetic Testing company. Frome, England

Notice NOT-OD-18-157 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Head of Bioinformatics 100,000 Genomes Project - Central London - Research Services Team! Paramount are working in partnership with Genomics England to expand their team in order to deliver success with the 100,000 Genomes Project. London, England

Notice NOT-OD-18-163 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-18-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to determine how immunity, generated by the initial and subsequent influenza infections and/or vaccinations, shapes protective immunity to future influenza exposures in longitudinal human infant cohorts to help inform the design of durable, broadly protective influenza vaccines.

Performing data investigation and preparation for analysis. Bachelor's Degree in Bioinformatics or related field....
From University of Washington - Thu, 05 Apr 2018 00:50:58 GMT - View all Seattle, WA jobs

Funding Opportunity RFA-AR-19-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing clinical projects. The ongoing parent clinical project can be an interventional clinical trial, or a clinical study such as an observational study that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Funding Opportunity RFA-AR-19-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing clinical projects. The ongoing parent clinical project can be an interventional clinical trial, or a clinical study such as an observational study that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Funding Opportunity PAR-18-743 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to urologic disorders research. Studies should address important clinical and translational questions that are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of prevention, diagnosis or treatment of urologic disorders.

Funding Opportunity PAR-18-744 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to support Exploratory/Developmental Research Grants (R21) that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. It is anticipated that some projects supported by these grants may lead to full-scale clinical studies including diagnostic strategies, epidemiological studies, or randomized clinical trials of diagnosis, prevention, or treatment of kidney diseases.

Negotiable: Paramount Recruitment: Software Developer - Bioinformatics Fixed Term Contract - Sept 2019 Cambridge This is a great opportunity for a strong Python or Perl developer to join a world-leading bioinformatics/ genomics organisation based in Cambridge. You will be responsible for Cambridge, England

Negotiable: Paramount Recruitment: Python Developer - Bioinformatics London Paramount are working in partnership with Genomics England to expand their team in order to deliver success Paramount are working in partnership with Genomics England to expand their team in order to with the 100, London, England

Funding Opportunity RFA-CA-18-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active NCI R01 research grants. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-18-019 (R01) and RFA-CA-18-020 (R21) . This FOA encourages research that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care. Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent R01 award.

Funding Opportunity RFA-CA-18-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites revision applications from investigators with active NCI U01 research grants. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-18-019 (R01) and RFA-CA-18-020 (R21) . This FOA encourages research that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care. Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent U01 award.